Literature DB >> 30766413

Health and Economic Burden of Nonalcoholic Fatty Liver Disease in the United States and Its Impact on Veterans.

Akshay Shetty1, Wing-Kin Syn1.   

Abstract

NAFLD is a leading cause of chronic liver disease and cirrhosis in the US and is associated with metabolic syndrome, type 2 diabetes, cardiovascular disease, and all-cause mortality.

Entities:  

Year:  2019        PMID： 30766413      PMCID： PMC6366581     

Source DB:  PubMed          Journal:  Fed Pract        ISSN： 1078-4497


  10 in total

1.  Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease.

Authors:  Nikhil Y Patil; Iulia Rus; Emma Downing; Ashok Mandala; Jacob E Friedman; Aditya D Joshi
Journal:  J Pharmacol Exp Ther       Date:  2022-08-06       Impact factor: 4.402

2.  Long-Term Outcomes of Previously Treated Adult and Adolescent Patients with Severe Hemophilia A Receiving Prophylaxis with Extended Half-Life FVIII Treatments: An Economic Analysis from a United Kingdom Perspective.

Authors:  Gary Benson; Tim Morton; Huw Thomas; Xin Ying Lee
Journal:  Clinicoecon Outcomes Res       Date:  2021-01-18

3.  A portable single-sided magnetic-resonance sensor for the grading of liver steatosis and fibrosis.

Authors:  Ashvin Bashyam; Chris J Frangieh; Siavash Raigani; Jeremy Sogo; Roderick T Bronson; Korkut Uygun; Heidi Yeh; Dennis A Ausiello; Michael J Cima
Journal:  Nat Biomed Eng       Date:  2020-11-30       Impact factor: 25.671

4.  Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.

Authors:  Ashwini Arvind; Jacqueline B Henson; Stephanie A Osganian; Cheryl Nath; Lara M Steinhagen; Zoe N Memel; Arley Donovan; Oluwafemi Balogun; Raymond T Chung; Tracey G Simon; Kathleen E Corey
Journal:  Hepatol Commun       Date:  2021-09-02

5.  Effects of exercise on high-fat diet-induced non-alcoholic fatty liver disease and lipid metabolism in ApoE knockout mice.

Authors:  Wen-Ching Huang; Jin-Wei Xu; Shiming Li; Xin Er Ng; Yu-Tang Tung
Journal:  Nutr Metab (Lond)       Date:  2022-02-16       Impact factor: 4.169

6.  Machine learning using longitudinal prescription and medical claims for the detection of non-alcoholic steatohepatitis (NASH).

Authors:  Ozge Yasar; Patrick Long; Brett Harder; Hanna Marshall; Sanjay Bhasin; Suyin Lee; Mark Delegge; Stephanie Roy; Orla Doyle; Nadea Leavitt; John Rigg
Journal:  BMJ Health Care Inform       Date:  2022-03

7.  Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Sahil Khanna; John T Wilkins; Hongyan Ning; Norrina B Allen; Cora E Lewis; J Jeffrey Carr; Donald Lloyd-Jones; Lisa B VanWagner
Journal:  J Nutr Metab       Date:  2022-04-14

Review 8.  Bioengineered Multicellular Liver Microtissues for Modeling Advanced Hepatic Fibrosis Driven Through Non-Alcoholic Fatty Liver Disease.

Authors:  Hyun-Jong Cho; Han-Jun Kim; KangJu Lee; Soufian Lasli; Aly Ung; Tyler Hoffman; Rohollah Nasiri; Praveen Bandaru; Samad Ahadian; Mehmet R Dokmeci; Junmin Lee; Ali Khademhosseini
Journal:  Small       Date:  2021-03-09       Impact factor: 13.281

9.  Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population.

Authors:  Sneha S Pillai; Hari Vishal Lakhani; Mishghan Zehra; Jiayan Wang; Anum Dilip; Nitin Puri; Kathleen O'Hanlon; Komal Sodhi
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923

10.  Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease.

Authors:  Hee Kyung Shin; Jeong Hwan Park; Jung Hwan Yu; Young-Joo Jin; Young Ju Suh; Jin-Woo Lee; Won Kim
Journal:  Sci Rep       Date:  2021-09-09       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.